Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Emerson Electric Co.

EMR

HIGHLY FAVORABLE

May 27, 2026

Research Conclusion

EMR is a structurally mispriced software-industrial platform. AspenTech (60-70% process simulation market share, $900M+ ARR, 30-year switching costs) embedded in legacy industrial multiples (16-19x Adj EPS) creates 25% discount to composite fair value. BUY at $133; PWFV $159 (+20%); Fair Value $166 (+25%). Strong Add below $120 (P/FY2027E Adj EPS ~17x).

Company Overview & Moat Assessment

Emerson Electric is a 135-year-old industrial manufacturer that underwent significant strategic transformation (2021-2025) under CEO Karsanbhai. Legacy conglomerate divested and rebuilt as pure-play industrial automation platform via acquisitions of NI Corporation ($8.2B, 2023) and AspenTech full control ($6.6B, 2025). Post-transformation structure: Intelligent Devices (process control valves, flow meters, sensors—$14.5B installed base in refineries, chemical plants, LNG facilities) and Software & Control (DeltaV/Ovation DCS, AspenTech industrial AI, NI test automation). AspenTech is the crown jewel: 60-70% market share in process simulation software, $900M+ ARR, 8-12% organic growth, switching costs measured in decades ($50-200M per-plant implementation). Adj EPS ~$5.95 FY2025; guided $6.30 FY2026E. FY ends September 30.

▲ Bull Case

  • AspenTech software re-rating: $900M ARR × 25-30x comps = $22.5B standalone value; current market values entire EMR at 19x Adj EPS; when sum-of-parts forces disaggregation, EMR re-rates to 26-27x; Adj EPS $9.00 FY2028 × 26x = $234 target (+76%)
  • LNG supercycle + AI data center power automation: 3-5 major LNG FIDs (Calcasieu Pass 2, Driftwood) in 2026-2027 unlock $150-500M per project orders; AI hyperscaler data centers opening $5-15B new TAM for Ovation power management; combined adds $800M-1.5B FY2028 revenue not in consensus; Q1 FY2026 Ovation +74% signals demand initiation
  • AspenTech synergies ahead of schedule: Full ownership (March 2025) unlocks cross-sell; EMR hardware customers convert to AspenTech software; AspenTech customers adopt EMR hardware; ARR growth accelerates to 15%+; margin beats guidance; integration premium compounds

▼ Bear Case

  • Oil below $60/bbl + LNG FID freeze: Crude WTI falls below $60; all LNG projects indefinitely on hold; Ovation orders collapse from +74% to -30%; EMR loses $400-600M revenue via cancellations; Adj EPS compresses to $6.00 FY2027; P/E reverts to 17x trough = $102 downside (-23%)
  • AspenTech ARR growth stalls below 6%: AVEVA (Schneider) and Honeywell Forge win major process simulation RFPs; AspenTech loses marquee contracts; ARR growth decelerates to 5%; market prices goodwill impairment risk; EMR P/E compresses to 16-17x; integration premium evaporates
  • NI semiconductor cycle trough: Test & Measurement highly correlated to semiconductor CapEx; new down-cycle (like 2022-2023) drives NI revenue down 15-20%; drags overall EMR revenue and margin; Adj EPS $6.50 at 18x = $117 (-12%) if other segments compensate
Primary Debate on Wall Street

Primary question: 'Is EMR's AspenTech acquisition a permanent re-rating event, or is software moat already priced in at 19-21x?' Bull case: AspenTech dramatically undervalued within EMR. $900M ARR × 20-25x = $18-22.5B value; market has never formally disaggregated software from hardware; catalyst is ARR disclosure or activist sum-of-parts forcing; hardware (Honeywell Process Solutions comps) 16-18x EBITDA = $55-65B; combined = $73-87.5B vs. $74.5B today; software essentially free. Bear case: Market already prices AspenTech at 19-21x multiple (premium vs. 17-18x pre-transformation); $11.6B net debt is ongoing drag; AVEVA, Honeywell Forge, SAP are aggressive competitors; AspenTech moat is real but not impenetrable. Our view: Bull is correct that market has not formally disaggregated software value. At $133 / 19x FY2027E Adj EPS, downside is limited (-23% to $102) while upside is material (PWFV $159, bull $234). BUY thesis requires clear ARR disclosure catalyst identification.

Top Catalysts
  • Q3 FY2026 earnings (Aug 2026): Ovation orders sustained +40%+ YoY organic growth — validates LNG and AI data center TAM thesis; probability 55%
  • AspenTech ARR disclosed as standalone quarterly metric — forces sum-of-parts re-rating; probability 30%
  • LNG FID announcement (Calcasieu Pass 2, Driftwood, or QatarEnergy) — $200-500M per project order visibility; probability 40%
  • FY2027 guidance $7.00+ Adj EPS (Nov 2026) — inflection point for multiple expansion from 19x to 22-24x; probability 50%
  • FY2026 Adj EPS guidance raise above $6.40 (Q3 2026) — confirms integration momentum ahead of consensus; probability 40%
Top Risks
  • Oil/LNG capex downturn (20% probability, High severity): WTI below $55-60 freezes LNG FIDs indefinitely; Ovation collapse drives -$400-600M revenue; mitigated by $7.9B backlog and non-LNG diversification
  • AspenTech ARR deceleration below 6% (15% probability, High severity): Competitive threats from AVEVA, SAP; signals moat erosion; mitigated by 3,000+ plant installations, 95%+ renewal rates, and $50-200M switching costs
  • Net Debt leverage $11.6B (20% probability, Moderate severity): Post-acquisition debt load; mitigated by IG rating, 2.4x net debt/EBITDA, organic deleveraging, no refinancing risk
  • Honeywell/AVEVA competition intensifies (20% probability, Moderate severity): Legacy competitors aggressively marketing against AspenTech; mitigated by 60-70% market share in $3B market, limited historical share erosion

Full Memo Continues

5 more sections, locked

  • Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/EMR/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.